The impact of diabetes mellitus on penile length in men undergoing inflatable penile prosthesis implantation.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4548619)

Published in Turk J Urol on September 01, 2013

Authors

Yiğit Akın1, İlker Fatih Şahiner2, Mustafa Faruk Usta2

Author Affiliations

1: Department of Urology, Faculty of Medicine, Erzincan University, Erzincan, Turkey.
2: Departmet of Urology, Faculty of Medicine, Akdeniz University, Antalya, Turkey.

Articles cited by this

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol (1994) 10.03

Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res (1985) 4.39

Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol (2000) 3.62

Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab (2001) 3.22

Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2004) 1.78

Serial assessment of efficacy and satisfaction profiles following penile prosthesis surgery. J Urol (2003) 1.43

Superoxide anion production in the rat penis impairs erectile function in diabetes: influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med (2005) 1.10

Diabetes, obesity, and erectile dysfunction. Gend Med (2009) 1.06

Factors influencing the outcomes of penile prosthesis surgery at a teaching institution. Urology (2003) 0.96

Surgical approaches for penile prosthesis implantation: penoscrotal vs infrapubic. Int J Impot Res (2003) 0.94

Penile prosthesis implantation. Urol Clin North Am (2001) 0.93

The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment. J Sex Med (2006) 0.92

Long-term infection rates in diabetic patients implanted with antibiotic-impregnated versus nonimpregnated inflatable penile prostheses: 7-year outcomes. Eur Urol (2011) 0.88

Morphologic changes in the arterial bed of the penis with aging. Relationship to the pathogenesis of impotence. Invest Urol (1977) 0.88

Erectile dysfunction in young non-obese type II diabetic Goto-Kakizaki rats is associated with decreased eNOS phosphorylation at Ser1177. J Sex Med (2010) 0.88

Nitric oxide-mediated corpus cavernosal smooth muscle relaxation is impaired in ageing and diabetes. BJU Int (2001) 0.87

Antibiotic coating reduces penile prosthesis infection. J Sex Med (2005) 0.86

Mentor Alpha 1 inflatable penile prosthesis: patient satisfaction and device reliability. Urology (1994) 0.86

Penile prosthesis infections. Int J Impot Res (2001) 0.82

Pharmacotherapeutic advances in the treatment of erectile dysfunction. Mayo Clin Proc (1999) 0.82

Do endocrines play an etiological role in diabetic and nondiabetic sexual dysfunctions? J Androl (1984) 0.82

Erectile dysfunction in the patient with diabetes mellitus. Am J Manag Care (2004) 0.81

Changes in the corpora cavernosa of impotent diabetics: comparing histological with clinical findings. J Urol (Paris) (1985) 0.78

Articles by these authors

Current medical treatment in pediatric urolithiasis. Turk J Urol (2013) 0.75